Skip to main content
NCBI home page
Nucleic Acids Research logoLink to Nucleic Acids Research
. 1997 Jul 15;25(14):2690–2693. doi: 10.1093/nar/25.14.2690

Peptide nucleic acid (PNA) is capable of enhancing hammerhead ribozyme activity with long but not with short RNA substrates.

E Jankowsky 1, G Strunk 1, B Schwenzer 1
PMCID: PMC146807  PMID: 9207013

Abstract

Long RNA substrates are inefficiently cleaved by hammerhead ribozymes in trans. Oligonucleotide facilitators capable of affecting the ribozyme activity by interacting with the substrates at the termini of the ribozyme provide a possibility to improve ribozyme mediated cleavage of long RNA substrates. We have examined the effect of PNA as facilitator in vitro in order to test if even artificial compounds have facilitating potential. Effects of 12mer PNA- (peptide nucleic acid), RNA- and DNA-facilitators of identical sequence were measured with three substrates containing either 942, 452 or 39 nucleotides. The PNA facilitator enhances the ribozyme activity with both, the 942mer and the 452mer substrate to a slightly smaller extent than RNA and DNA facilitators. This effect was observed up to PNA facilitator:substrate ratios of 200:1. The enhancement becomes smaller as the PNA facilitator:substrate ratio exceeds 200:1. With the 39mer substrate, the PNA facilitator decreases the ribozyme activity by more than 100-fold, even at PNA facilitator:substrate ratios of 1:1. Although with long substrates the effect of the PNA facilitator is slightly smaller than the effect of identical RNA or DNA facilitators, PNA may be a more practical choice for potential applications in vivo because PNA is much more resistant to degradation by cellular enzymes.

Full Text

The Full Text of this article is available as a PDF (106.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bertrand E., Pictet R., Grange T. Can hammerhead ribozymes be efficient tools to inactivate gene function? Nucleic Acids Res. 1994 Feb 11;22(3):293–300. doi: 10.1093/nar/22.3.293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Demidov V. V., Yavnilovich M. V., Belotserkovskii B. P., Frank-Kamenetskii M. D., Nielsen P. E. Kinetics and mechanism of polyamide ("peptide") nucleic acid binding to duplex DNA. Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2637–2641. doi: 10.1073/pnas.92.7.2637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Denman R. B. Cleavage of full-length beta APP mRNA by hammerhead ribozymes. Nucleic Acids Res. 1993 Aug 25;21(17):4119–4125. doi: 10.1093/nar/21.17.4119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Denman R. B. Facilitator oligonucleotides increase ribozyme RNA binding to full-length RNA substrates in vitro. FEBS Lett. 1996 Mar 11;382(1-2):116–120. doi: 10.1016/0014-5793(96)00125-1. [DOI] [PubMed] [Google Scholar]
  5. Egholm M., Buchardt O., Christensen L., Behrens C., Freier S. M., Driver D. A., Berg R. H., Kim S. K., Norden B., Nielsen P. E. PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules. Nature. 1993 Oct 7;365(6446):566–568. doi: 10.1038/365566a0. [DOI] [PubMed] [Google Scholar]
  6. Goodchild J. Enhancement of ribozyme catalytic activity by a contiguous oligodeoxynucleotide (facilitator) and by 2'-O-methylation. Nucleic Acids Res. 1992 Sep 11;20(17):4607–4612. doi: 10.1093/nar/20.17.4607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Haseloff J., Gerlach W. L. Simple RNA enzymes with new and highly specific endoribonuclease activities. Nature. 1988 Aug 18;334(6183):585–591. doi: 10.1038/334585a0. [DOI] [PubMed] [Google Scholar]
  8. Heidenreich O., Eckstein F. Hammerhead ribozyme-mediated cleavage of the long terminal repeat RNA of human immunodeficiency virus type 1. J Biol Chem. 1992 Jan 25;267(3):1904–1909. [PubMed] [Google Scholar]
  9. Herschlag D. Implications of ribozyme kinetics for targeting the cleavage of specific RNA molecules in vivo: more isn't always better. Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):6921–6925. doi: 10.1073/pnas.88.16.6921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Herschlag D., Khosla M., Tsuchihashi Z., Karpel R. L. An RNA chaperone activity of non-specific RNA binding proteins in hammerhead ribozyme catalysis. EMBO J. 1994 Jun 15;13(12):2913–2924. doi: 10.1002/j.1460-2075.1994.tb06586.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jankowsky E., Schwenzer B. Efficient improvement of hammerhead ribozyme mediated cleavage of long substrates by oligonucleotide facilitators. Biochemistry. 1996 Dec 3;35(48):15313–15321. doi: 10.1021/bi961397f. [DOI] [PubMed] [Google Scholar]
  12. Jankowsky E., Schwenzer B. Oligonucleotide facilitators may inhibit or activate a hammerhead ribozyme. Nucleic Acids Res. 1996 Feb 1;24(3):423–429. doi: 10.1093/nar/24.3.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Knudsen H., Nielsen P. E. Antisense properties of duplex- and triplex-forming PNAs. Nucleic Acids Res. 1996 Feb 1;24(3):494–500. doi: 10.1093/nar/24.3.494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mahieu M., Hendrix C., Ooms J., Herdewijn P., Content J. In vitro NCp7 enhancement of ribozyme-mediated cleavage of full-length human IL-6 mRNA. Biochem Biophys Res Commun. 1995 Sep 5;214(1):36–43. doi: 10.1006/bbrc.1995.2253. [DOI] [PubMed] [Google Scholar]
  15. Marschall P., Thomson J. B., Eckstein F. Inhibition of gene expression with ribozymes. Cell Mol Neurobiol. 1994 Oct;14(5):523–538. doi: 10.1007/BF02088835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Müller G., Strack B., Dannull J., Sproat B. S., Surovoy A., Jung G., Moelling K. Amino acid requirements of the nucleocapsid protein of HIV-1 for increasing catalytic activity of a Ki-ras ribozyme in vitro. J Mol Biol. 1994 Sep 30;242(4):422–429. doi: 10.1006/jmbi.1994.1592. [DOI] [PubMed] [Google Scholar]
  17. Nielsen P. E., Egholm M., Berg R. H., Buchardt O. Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science. 1991 Dec 6;254(5037):1497–1500. doi: 10.1126/science.1962210. [DOI] [PubMed] [Google Scholar]
  18. Perkins T. A., Wolf D. E., Goodchild J. Fluorescence resonance energy transfer analysis of ribozyme kinetics reveals the mode of action of a facilitator oligonucleotide. Biochemistry. 1996 Dec 17;35(50):16370–16377. doi: 10.1021/bi961234r. [DOI] [PubMed] [Google Scholar]
  19. Sarver N., Cantin E. M., Chang P. S., Zaia J. A., Ladne P. A., Stephens D. A., Rossi J. J. Ribozymes as potential anti-HIV-1 therapeutic agents. Science. 1990 Mar 9;247(4947):1222–1225. doi: 10.1126/science.2107573. [DOI] [PubMed] [Google Scholar]
  20. Scarabino D., Tocchini-Valentini G. P. Influence of substrate structure on cleavage by hammerhead ribozyme. FEBS Lett. 1996 Apr 1;383(3):185–190. doi: 10.1016/0014-5793(96)00242-6. [DOI] [PubMed] [Google Scholar]
  21. Scarpati E. M., Wen D., Broze G. J., Jr, Miletich J. P., Flandermeyer R. R., Siegel N. R., Sadler J. E. Human tissue factor: cDNA sequence and chromosome localization of the gene. Biochemistry. 1987 Aug 25;26(17):5234–5238. doi: 10.1021/bi00391a004. [DOI] [PubMed] [Google Scholar]
  22. Symons R. H. Small catalytic RNAs. Annu Rev Biochem. 1992;61:641–671. doi: 10.1146/annurev.bi.61.070192.003233. [DOI] [PubMed] [Google Scholar]
  23. Uhlenbeck O. C. A small catalytic oligoribonucleotide. Nature. 1987 Aug 13;328(6131):596–600. doi: 10.1038/328596a0. [DOI] [PubMed] [Google Scholar]
  24. Woisard A., Fourrey J. L., Favre A. Multiple folded conformations of a hammerhead ribozyme domain under cleavage conditions. J Mol Biol. 1994 Jun 10;239(3):366–370. doi: 10.1006/jmbi.1994.1378. [DOI] [PubMed] [Google Scholar]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES